Financial Services company CARE Ratings announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations: Rs 109.7 crore for Q4FY25, change 22% YoY. EBITDA: Rs 47.4 crore for Q4FY25, change 63% YoY. EBITDA margin: 43% for Q4FY25. PAT: Rs 43.4 crore for Q4FY25, change 77% YoY. PAT margin: 35% for Q4FY25. FY25 Financial Highlights: Revenue from Operations: Rs 402.3 crore for FY25, change 21% YoY. EBITDA: Rs 155.3 crore for FY25, change 39% YoY. EBITDA margin: 39% for FY25. PAT: Rs 140.0 crore for FY25, change 37% YoY. PAT margin: 31% for FY25. Mehul Pandya, Managing Director & Group CEO, Care Edge, said: “In FY25, CARE Ratings Ltd. achieved its highest-ever standalone and consolidated income from operations, registering year-on-year growth of 19% and 21%, respectively. This performance reflects our steadfast commitment to quality-led growth. Our standalone ratings business continued to demonstrate strong traction, particularly in initial ratings of capital market instruments, securitisation, and bank debt. The consolidated performance was further bolstered by an enhanced contribution from our non-ratings businesses, aided by strong showing from our overseas rating subsidiaries. The standalone EBITDA improved by 22%, underscoring our continued focus on operational efficiency. Other income also improved, supported by better yields from treasury investments. As a result, standalone PAT registered a healthy growth of 24% over the previous year. At the consolidated level, the EBITDA margin improved from 34% to 39%, reflecting significantly improved performance across our subsidiaries. Consolidated PAT margin improved from 27% to 31%, reinforcing the strength and scalability of our increasingly diversified business lines. For Q4FY25, we recorded a 22% year-on-year growth in both standalone and consolidated income from operations. Notably, standalone and consolidated PAT for the quarter grew by 29% and 77%, respectively, marking a substantial improvement in profitability across the Group. Built on strong foundations, clear vision and an unwavering commitment to quality, CareEdge is well-positioned for long-term success. I am happy to share that The Board of Directors has recommended a final dividend of Rs 11/- per share (of Rs 10/-face value) which will take the total dividend declared for the year to Rs 18/- per share." Result PDF